Home
Conditions
HIV Seropositivity

Clinical trial condition

HIV Seropositivity

Explore clinical trials studying HIV Seropositivity. Study availability and eligibility vary by location and protocol.

160 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

HIV Seropositivity trial results

Completed

A Study of Zidovudine in HIV-Infected Patients With Liver Disease

NCT00001001

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Boston Med Ctr Boston, Massachusetts, United States

Univ of Massachusetts Med Ctr Worcester, Massachusetts, United States

Univ of North Carolina Chapel Hill, North Carolina, United States

Milton S Hershey Med Ctr Hershey, Pennsylvania, United States

View Trial Details

Completed

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

NCT00000977

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Stanford CRS Palo Alto, California, United States

NY Univ. HIV/AIDS CRS New York, United States

View Trial Details

Completed

A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

NCT00001005

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Duke Univ. Med. Ctr. Adult CRS Durham, North Carolina, United States

View Trial Details

Completed

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

NCT00000667

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations: NY Univ. HIV/AIDS CRS New York, United States

View Trial Details

Completed

A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects

NCT00000713

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Univ of Pittsburgh Med School Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms

NCT00000707

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +30 more
Locations: SUNY - Stony Brook Stony Brook, New York, United States

View Trial Details

Completed

Alveolar Macrophage Proteomics in HIV-associated Emphysema

NCT00823927

Conditions: Behavior, Blood-Borne Infections, Cigarette Smoking, +21 more
Locations: The Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Gardasil Immunogenicity With Needle-Free Injection

NCT01924754

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: University of California, San Francisco San Francisco, California, United States

Thai Red Cross AIDS Research Centre Bangkok, Thailand

View Trial Details

Completed

Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir

NCT03374358

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +21 more
Locations: Aurora hospital, Department of Infectious Diseases Helsinki, Finland

View Trial Details

Completed

Regional Differences in Human Immunodeficiency Virus (HIV) Testing

NCT03158987

Conditions: Blood-Borne Infections, CD4+ T Lymphocytopenia, Communicable Diseases, +20 more
Locations: University Hospital Jena Jena, Thuringia, Germany

View Trial Details

HIV Seropositivity

HIV Seropositivity trial results

Related conditions